STOCK TITAN

Paychex (PAYX) director Joseph Velli exercises 10,220 options, holds 89,564 shares

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PAYCHEX INC director Joseph M. Velli reported a routine options exercise. He exercised stock options covering 10,220 shares of common stock at an exercise price of $60.59 per share, described as options approaching their 10-year expiration date. Following the exercise, he directly holds 89,564 shares of PAYCHEX common stock.

He continues to hold multiple stock option awards on PAYCHEX common stock, with exercise prices ranging from $57.20 to $140.68 and expiration dates between 2027 and 2035. The filing shows an option exercise but no reported open-market sale of shares.

Positive

  • None.

Negative

  • None.
Insider VELLI JOSEPH M
Role null
Type Security Shares Price Value
Exercise Stock Option 10,220 $0.00 --
Exercise Common Stock 10,220 $60.59 $619K
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
Holdings After Transaction: Stock Option — 0 shares (Direct, null); Common Stock — 89,564 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options exercised 10,220 shares Common stock acquired via option exercise (code M)
Exercise price $60.59/share Price for exercised stock options
Shares held after 89,564 shares Direct PAYCHEX common stock ownership after transaction
Remaining option exercise prices (low) $57.20/share Lowest exercise price among remaining stock options
Remaining option exercise prices (high) $140.68/share Highest exercise price among remaining stock options
Option expiration (exercised grant) July 6, 2026 Expiration date of options exercised in this filing
Earliest remaining option expiration July 12, 2027 Earliest expiration among remaining option grants
Latest remaining option expiration October 14, 2035 Latest expiration among remaining option grants
Stock Option financial
"security_title: "Stock Option" with underlying security title "Common Stock""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise price financial
"conversion_or_exercise_price: "60.5900" and other option records"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date fields such as "2026-07-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
non-derivative financial
"transaction_type: "non-derivative" for common stock entry"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VELLI JOSEPH M

(Last)(First)(Middle)
911 PANORAMA TRAIL SOUTH

(Street)
ROCHESTER NEW YORK 14625

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/08/2026M10,220(1)A$60.5989,564D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$60.5905/08/2026M10,22007/07/201707/06/2026Common Stock10,220$00D
Stock Option$57.207/13/201807/12/2027Common Stock9,6159,615D
Stock Option$70.3707/12/201907/11/2028Common Stock8,6418,641D
Stock Option$85.3307/11/202007/10/2029Common Stock7,9297,929D
Stock Option$73.5307/15/202107/14/2030Common Stock5,7935,793D
Stock Option$112.6707/15/202207/14/2031Common Stock5,0755,075D
Stock Option$11507/15/202307/14/2032Common Stock3,0273,027D
Stock Option$120.8607/15/202407/14/2033Common Stock3,3823,382D
Stock Option$121.6307/15/202507/14/2034Common Stock3,3513,351D
Stock Option$140.6807/15/202607/14/2035Common Stock670670D
Stock Option$127.5210/15/202610/14/2035Common Stock3,0613,061D
Explanation of Responses:
1. Exercise of stock options approaching 10-year expiration date.
Prabha S. Bhandari, Attorney-in-fact05/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PAYCHEX (PAYX) director Joseph M. Velli report in this Form 4?

Joseph M. Velli reported exercising stock options for 10,220 PAYCHEX common shares at $60.59 per share. The filing records this as an option exercise, not an open-market purchase or sale, and updates his direct share ownership position.

How many PAYCHEX (PAYX) shares does Joseph M. Velli hold after the transaction?

After exercising options, Joseph M. Velli directly holds 89,564 shares of PAYCHEX common stock. This figure reflects his updated ownership position as of the transaction date disclosed in the Form 4 filing.

What was the exercise price of the PAYCHEX (PAYX) options used in this transaction?

The exercised PAYCHEX stock options carried an exercise price of $60.59 per share. Exercising these options converted derivative rights into 10,220 shares of common stock at that fixed price, as disclosed in the Form 4.

Does the PAYCHEX (PAYX) Form 4 show Joseph M. Velli selling any shares?

The Form 4 shows an options exercise coded as a derivative exercise (code M) and does not report any open-market sale transactions. It reflects the acquisition of shares through option exercise, not a sale into the market.

What does the footnote in the PAYCHEX (PAYX) Form 4 indicate about the options exercise?

The footnote explains that the transaction was an exercise of stock options approaching their 10-year expiration date. This suggests the timing was driven by the options’ term rather than by a new open-market trading decision.

What stock options does Joseph M. Velli continue to hold in PAYCHEX (PAYX)?

He continues to hold several PAYCHEX stock option grants with exercise prices between $57.20 and $140.68. These options have expiration dates ranging from 2027 through 2035, providing ongoing rights to acquire additional common shares.